A sensitive blood test has been developed to detect a protein biomarker of Alzheimer’s disease known as brain-derived tau.

A sensitive blood test has been developed to detect a protein biomarker of Alzheimer’s disease known as brain-derived tau.
Chemically driven nanomotors may help resolve chronic inflammation in patients with rheumatoid arthritis.
Stimulating neuron growth using a new mRNA therapy, researchers hope to treat chronic pain caused by disease, injury, or chemotherapy.
Artificial enzymes could help bring down the manufacturing costs of different medications, making them more available to patients.
Early results for an anti-seizure drug administered as a nasal spray show a more targeted approach to helping get seizures under control.
In the lab, a multi-functional hydrogel was shown to not only repair defects but also strengthen bone weakened by osteoporosis.
A new in situ, personalized cancer vaccine captures molecules from growing tumors to activate the body’s immune cells against them.
Living microrobots made from algae were weaponized to help fight tumors by improving the effectiveness of cancer therapies.
A new drug called momelotinib reduces the need for blood transfusions in anemic patients suffering from myelofibrosis.
Researchers identify a protein that stops the brain from connecting memories, and regulating it could help improve memory loss treatment.